Healthcare - Biotechnology - NASDAQ - DE
$ 8.17
-4.22 %
$ 975 M
Market Cap
-9.28
P/E
CASH FLOW STATEMENT
18.2 M
OPERATING CASH FLOW
-31.4 M
INVESTING CASH FLOW
84.5 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Immatics N.V.
| Net Income | -97 M |
| Depreciation & Amortization | 7.23 M |
| Capital Expenditures | -31 M |
| Stock-Based Compensation | 20.7 M |
| Change in Working Capital | 81.6 M |
| Others | 71.6 M |
| Free Cash Flow | -12.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (97.0) | 37.5 | (93.3) | (229.6) | (32.5) | (32.4) |
| Depreciation & Amortization | 7.2 | 7.0 | 5.3 | 4.4 | 3.9 | 2.2 |
| Deferred Income Tax | 18.7 | 4.5 | 11.2 | (4.0) | 0.6 | 0.5 |
| Stock Based Compensation | 20.7 | 22.6 | 26.4 | 23.0 | 0.9 | 1.5 |
| Other Operating Activities | (13.0) | (8.7) | 0.4 | 145.9 | 1.2 | (0.3) |
| Change in Working Capital | 81.6 | 37.3 | (31.7) | (25.3) | 96.9 | 49.2 |
| Cash From Operations | 18.2 | 100.1 | (81.8) | (85.6) | 71.0 | 20.7 |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (31.0) | (6.2) | (5.7) | (7.5) | (2.2) | (0.5) |
| Other Items | (0.4) | (203.6) | 13.2 | (8.4) | (2.8) | (13.0) |
| Cash From Investing Activities | (31.4) | (209.8) | 7.5 | (15.9) | (5.1) | (13.5) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (3.8) | (2.8) | (2.7) | (2.1) | (1.9) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.0) | (7.9) | 0 | (7.9) | 0 | 0 |
| Cash From Financing Activities | 84.5 | 123.7 | (2.6) | 207.9 | (1.9) | 23.6 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 70.0 | 15.5 | (74.5) | 104.2 | 64.0 | 31.0 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (12.7) | 93.9 | (87.4) | (93.1) | 68.7 | 20.2 |